全文获取类型
收费全文 | 19287篇 |
免费 | 1492篇 |
国内免费 | 1073篇 |
出版年
2024年 | 32篇 |
2023年 | 205篇 |
2022年 | 510篇 |
2021年 | 903篇 |
2020年 | 601篇 |
2019年 | 738篇 |
2018年 | 827篇 |
2017年 | 550篇 |
2016年 | 849篇 |
2015年 | 1153篇 |
2014年 | 1308篇 |
2013年 | 1466篇 |
2012年 | 1767篇 |
2011年 | 1555篇 |
2010年 | 964篇 |
2009年 | 847篇 |
2008年 | 1068篇 |
2007年 | 933篇 |
2006年 | 822篇 |
2005年 | 731篇 |
2004年 | 585篇 |
2003年 | 549篇 |
2002年 | 472篇 |
2001年 | 358篇 |
2000年 | 295篇 |
1999年 | 288篇 |
1998年 | 180篇 |
1997年 | 137篇 |
1996年 | 105篇 |
1995年 | 111篇 |
1994年 | 78篇 |
1993年 | 70篇 |
1992年 | 97篇 |
1991年 | 96篇 |
1990年 | 87篇 |
1989年 | 68篇 |
1988年 | 56篇 |
1987年 | 53篇 |
1986年 | 39篇 |
1985年 | 44篇 |
1984年 | 23篇 |
1983年 | 23篇 |
1982年 | 21篇 |
1981年 | 13篇 |
1979年 | 20篇 |
1978年 | 16篇 |
1977年 | 19篇 |
1976年 | 15篇 |
1975年 | 14篇 |
1972年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
751.
752.
Yunkai Wang Yajun Hong Chunyu Zhang Yunli Shen Ye Shen Pan Rui Zhen Chen Qi Zhang Yi Han Chen 《Journal of cellular and molecular medicine》2019,23(1):464-475
Picroside II (P‐II), one of the main active components of scrophularia extract, which have anti‐oxidative, anti‐inflammatory effects, but its effect on hyperhomocysteinemia (HHcy) induced endothelial injury remains to be determined. Here, we test whether P‐II protects HHcy‐induced endothelial dysfunction against oxidative stress, inflammation and cell apoptosis. In vitro study using HUVECs, and in hyperhomocysteinemia mouse models, we found that HHcy decreased endothelial SIRT1 expression and increased LOX‐1 expression, subsequently causing reactive oxygen species generation, up‐regulation of NADPH oxidase activity and NF‐κB activation, thereby promoting pro‐inflammatory response and cell apoptosis. Blockade of Sirt1 with Ex527 or siRNASIRT1 increased LOX‐1 expression, whereas overexpression of SIRT1 decreased LOX‐1 expression markedly. P‐II treatment significantly increased SIRT1 expression and reduced LOX‐1 expression, and protected against endothelial cells from Hcy‐induced oxidative injury, inflammation and apoptosis. However, blockade of SIRT1 or overexpression of LOX‐1 attenuated the therapeutic effects of P‐II. In conclusion, our results suggest that P‐II prevents the Hcy induced endothelial damage probably through regulating the SIRT1/LOX‐1 signaling pathway. 相似文献
753.
Bo Wang Deliang Shen Junnan Tang Jing Li Yue Xiao Xiuying Chen Chang Cao Dongjian Han Erhe Gao Wen Zhao Jinying Zhang Junbiao Chang 《Journal of cellular and molecular medicine》2019,23(9):6048-6059
Sodium (±)‐5‐bromo‐2‐(a‐hydroxypentyl) benzoate (generic name: brozopine, BZP) has been reported to protect against stroke‐induced brain injury and was approved for Phase II clinical trials for treatment of stroke‐related brain damage by the China Food and Drug Administration (CFDA). However, the role of BZP in cardiac diseases, especially in pressure overload‐induced cardiac hypertrophy and heart failure, remains to be investigated. In the present study, angiotensin II stimulation and transverse aortic constriction were employed to induce cardiomyocyte hypertrophy in vitro and in vivo, respectively, prior to the assessment of myocardial cell autophagy. We observed that BZP administration ameliorated cardiomyocyte hypertrophy and excessive autophagic activity. Further results indicated that AMP‐activated protein kinase (AMPK)‐mediated activation of the mammalian target of rapamycin (mTOR) pathway likely played a role in regulation of autophagy by BZP after Ang II stimulation. The activation of AMPK with metformin reversed the BZP‐induced suppression of autophagy. Finally, for the first time, we demonstrated that BZP could protect the heart from pressure overload‐induced hypertrophy and dysfunction, and this effect is associated with its inhibition of maladaptive cardiomyocyte autophagy through the AMPK‐mTOR signalling pathway. These findings indicated that BZP may serve as a promising compound for treatment of pressure overload‐induced cardiac remodelling and heart failure. 相似文献
754.
755.
Kyoungjune Pak Yun Hak Kim Sunghwan Suh Tae Sik Goh Dae Cheon Jeong Seong Jang Kim In Joo Kim Myoung‐Eun Han Sae‐Ock Oh 《Journal of cellular and molecular medicine》2019,23(4):3010-3015
As the importance of personalized therapeutics in aggressive papillary thyroid cancer (PTC) increases, accurate risk stratification is required. To develop a novel prognostic scoring system for patients with PTC (n = 455), we used mRNA expression and clinical data from The Cancer Genome Atlas. We performed variable selection using Network‐Regularized high‐dimensional Cox‐regression with gene network from pathway databases. The risk score was calculated using a linear combination of regression coefficients and mRNA expressions. The risk score and clinical variables were assessed by several survival analyses. The risk score showed high discriminatory power for the prediction of event‐free survival as well as the presence of metastasis. In multivariate analysis, the risk score and presence of metastasis were significant risk factors among the clinical variables that were examined together. In the current study, we developed a risk scoring system that will help to identify suitable therapeutic options for PTC. 相似文献
756.
757.
758.
Pengfei Diao Han Ge Yue Song Yaping Wu Jin Li Zhongwu Li Jianrong Yang Yanling Wang Jie Cheng 《Journal of cellular and molecular medicine》2019,23(6):4269-4280
The long noncoding RNAs (lncRNAs) have been increasingly appreciated as key players underlying tumourigenesis and hold great potentials as prognostic biomarkers and therapeutic targets. However, their roles in head neck squamous cell carcinoma (HNSCC) have remained incompletely known. Here, we sought to reveal the oncogenic roles and clinical significance of a tumour‐associated lncRNA, zinc finger E‐box binding homeobox 2 antisense RNA 1 (ZEB2‐AS1), in HNSCC. ZEB2‐AS1 was aberrantly overexpressed in a fraction of HNSCC samples. Its overexpression significantly associated with large tumour size, cervical node metastasis and reduced overall and disease‐free survival. Antisense oligonucleotides (ASO)‐mediated ZEB2‐AS1 depletion markedly inhibited cell proliferation, migration and invasion while triggered apoptosis in HNSCC cells in part via modulating ZEB2 mRNA stability. Enforced overexpression of ZEB2 largely attenuated the phenotypic changes resulted from ZEB2‐AS1 inhibition except the impaired cell proliferation. In addition, ZEB2‐AS1 was required for TGF‐β1‐induced epithelial‐mesenchymal transition (EMT) in vitro. Significantly reduced tumour growth and lung metastasis were observed in ZEB2‐AS1‐depleted cells in HNSCC xenograft animal models. Taken together, our findings reveal that overexpression of ZEB2‐AS1 associates with tumour aggressiveness and unfavourable prognosis by serving as a putative oncogenic lncRNA and a novel prognostic biomarker in HNSCC. 相似文献
759.
Feng Zhou Jingtian Mei Kai Yuan Xiuguo Han Han Qiao Tingting Tang 《Journal of cellular and molecular medicine》2019,23(6):4395-4407
Increasing evidence indicates that osteoarthritis (OA) is a musculoskeletal disease affecting the whole joint, including both cartilage and subchondral bone. Reactive oxygen species (ROS) have been demonstrated to be one of the important destructive factors during early‐stage OA development. The objective of this study was to investigate isorhamnetin (Iso) treatment on osteoclast formation and chondrocyte protection to attenuate OA by modulating ROS. Receptor activator of nuclear factor‐kappa B ligand (RANKL) was used to establish the osteoclast differentiation model in bone marrow macrophages (BMMs) in vivo. H2O2 was used to induce ROS, which could further cause chondrocyte apoptosis. We demonstrated that Iso suppressed RANKL‐induced ROS generation, which could mediate osteoclastogenesis. Moreover, we found that Iso inhibited osteoclast formation and function by suppressing the expression of osteoclastogenesis‐related genes and proteins. We proved that Iso inhibited RANKL‐induced activation of mitogen‐activated protein kinase activation of mitogen‐activated protein kinase (MAPK), nuclear factor‐kappa B (NF‐κB) and AKT signalling pathways in BMMs. In addition, Iso inhibited ROS‐induced chondrocyte apoptosis by regulating apoptosis‐related proteins. Moreover, Iso was administered to an anterior cruciate ligament transection (ACLT)‐induced OA mouse model. The results indicated that Iso exerted beneficial effects on inhibiting excessive osteoclast activity and chondrocyte apoptosis, which further remedied cartilage damage. Overall, our data showed that Iso is an effective candidate for treating OA. 相似文献
760.
Hongrui Sun Jing Zhang Xinlei Gan Luting Yu Haobo Yuan Minghui Shang Chaojie Lu Dagang Hou Ziyang Hu Yuejin Zhu Liyuan Han 《Liver Transplantation》2019,9(25)
Fabrication of efficient Pb reduced inorganic CsPbI2Br perovskite solar cells (PSC) are an important part of environment‐friendly perovskite technology. In this work, 10% Pb reduction in CsPb0.9Zn0.1I2Br promotes the efficiency of PSCs to 13.6% (AM1.5, 1sun), much higher than the 11.8% of the pure CsPbI2Br solar cell. Zn2+ has stronger interaction with the anions to manipulate crystal growth, resulting in size‐enlarged crystallite with enhanced growth orientation. Moreover, the grain boundaries (GBs) are passivated by the Cs‐Zn‐I/Br compound. The high quality CsPb0.9Zn0.1I2Br greatly diminishes the GB trap states and facilitates the charge transport. Furthermore, the Zn4s‐I5p states slightly reduce the energy bandgap, accounting for the wider solar spectrum absorption. Both the crystalline morphology and energy state change benefit the device performance. This work highlights a nontoxic and stable Pb reduction method to achieve efficient inorganic PSCs. 相似文献